une lettre<\/a> (en anglais) au Conseil d’examen du prix des m\u00e9dicaments brevet\u00e9s (PMPRB) pour lui expliquer les cons\u00e9quences de taille que pourrait avoir cette d\u00e9cision sur les soins aux patients. La SCE continue de militer en faveur de meilleurs soins et de meilleures options de traitement pour les patients, ce qui inclut un acc\u00e8s plus facile \u00e0 des nouveaux m\u00e9dicaments r\u00e9volutionnaires.<\/p>\n","protected":false},"excerpt":{"rendered":"D\u00e9fendre les patients lors des discussions sur le prix des m\u00e9dicaments La SCE a appris r\u00e9cemment que les changements propos\u00e9s concernant la mani\u00e8re dont les prix des m\u00e9dicaments sont fix\u00e9s au Canada (le R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s) pourraient avoir une incidence n\u00e9gative sur les Canadiens atteints de dermatite atopique, couramment appel\u00e9e \u00ab ecz\u00e9ma \u00bb. […]<\/p>\n","protected":false},"author":4,"featured_media":2400,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[47],"tags":[],"class_list":["post-3778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-activites-de-defense-de-droits-et-dinterets"],"acf":[],"yoast_head":"\n
La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l'\u00e9tablissement des prix des m\u00e9dicaments | Eczema Society of Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l'\u00e9tablissement des prix des m\u00e9dicaments | Eczema Society of Canada\" \/>\n<meta property=\"og:description\" content=\"D\u00e9fendre les patients lors des discussions sur le prix des m\u00e9dicaments La SCE a appris r\u00e9cemment que les changements propos\u00e9s concernant la mani\u00e8re dont les prix des m\u00e9dicaments sont fix\u00e9s au Canada (le R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s) pourraient avoir une incidence n\u00e9gative sur les Canadiens atteints de dermatite atopique, couramment appel\u00e9e \u00ab ecz\u00e9ma \u00bb. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/\" \/>\n<meta property=\"og:site_name\" content=\"Eczema Society of Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EczemaSocietyofCanada\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-17T15:14:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-01T17:33:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1880\" \/>\n\t<meta property=\"og:image:height\" content=\"1255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ESCAdmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:site\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"ESCAdmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/\"},\"author\":{\"name\":\"ESCAdmin\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/person\\\/4d95056924d0f5c8b391739699691790\"},\"headline\":\"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l’\u00e9tablissement des prix des m\u00e9dicaments\",\"datePublished\":\"2020-08-17T15:14:39+00:00\",\"dateModified\":\"2024-11-01T17:33:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/\"},\"wordCount\":220,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/pexels-photo-1181208.jpeg\",\"articleSection\":[\"Activit\u00e9s de d\u00e9fense de droits et d\u2019int\u00e9r\u00eats\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/\",\"name\":\"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l'\u00e9tablissement des prix des m\u00e9dicaments | Eczema Society of Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/pexels-photo-1181208.jpeg\",\"datePublished\":\"2020-08-17T15:14:39+00:00\",\"dateModified\":\"2024-11-01T17:33:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/pexels-photo-1181208.jpeg\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/pexels-photo-1181208.jpeg\",\"width\":1880,\"height\":1255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/esc-advocates-for-patients-during-drug-pricing-discussions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l’\u00e9tablissement des prix des m\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"name\":\"Eczema Society of Canada\",\"description\":\"Educational Resources\",\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eczemahelp.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\",\"name\":\"Eczema Society of Canada\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"width\":362,\"height\":360,\"caption\":\"Eczema Society of Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EczemaSocietyofCanada\",\"https:\\\/\\\/x.com\\\/EczemaSocietyCA\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/EczemaHelp\",\"https:\\\/\\\/www.instagram.com\\\/eczemasocietyofcanada\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/person\\\/4d95056924d0f5c8b391739699691790\",\"name\":\"ESCAdmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/d59cdb18d6c9c6fecc51727424cc12fc.jpg?ver=1776804733\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/d59cdb18d6c9c6fecc51727424cc12fc.jpg?ver=1776804733\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/d59cdb18d6c9c6fecc51727424cc12fc.jpg?ver=1776804733\",\"caption\":\"ESCAdmin\"},\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/author\\\/escadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l'\u00e9tablissement des prix des m\u00e9dicaments | Eczema Society of Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/","og_locale":"fr_FR","og_type":"article","og_title":"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l'\u00e9tablissement des prix des m\u00e9dicaments | Eczema Society of Canada","og_description":"D\u00e9fendre les patients lors des discussions sur le prix des m\u00e9dicaments La SCE a appris r\u00e9cemment que les changements propos\u00e9s concernant la mani\u00e8re dont les prix des m\u00e9dicaments sont fix\u00e9s au Canada (le R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s) pourraient avoir une incidence n\u00e9gative sur les Canadiens atteints de dermatite atopique, couramment appel\u00e9e \u00ab ecz\u00e9ma \u00bb. […]","og_url":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/","og_site_name":"Eczema Society of Canada","article_publisher":"https:\/\/www.facebook.com\/EczemaSocietyofCanada","article_published_time":"2020-08-17T15:14:39+00:00","article_modified_time":"2024-11-01T17:33:32+00:00","og_image":[{"width":1880,"height":1255,"url":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208.jpeg","type":"image\/jpeg"}],"author":"ESCAdmin","twitter_card":"summary_large_image","twitter_creator":"@EczemaSocietyCA","twitter_site":"@EczemaSocietyCA","twitter_misc":{"\u00c9crit par":"ESCAdmin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#article","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/"},"author":{"name":"ESCAdmin","@id":"https:\/\/eczemahelp.ca\/#\/schema\/person\/4d95056924d0f5c8b391739699691790"},"headline":"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l’\u00e9tablissement des prix des m\u00e9dicaments","datePublished":"2020-08-17T15:14:39+00:00","dateModified":"2024-11-01T17:33:32+00:00","mainEntityOfPage":{"@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/"},"wordCount":220,"commentCount":0,"publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"image":{"@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#primaryimage"},"thumbnailUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208.jpeg","articleSection":["Activit\u00e9s de d\u00e9fense de droits et d\u2019int\u00e9r\u00eats"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/","url":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/","name":"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l'\u00e9tablissement des prix des m\u00e9dicaments | Eczema Society of Canada","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#primaryimage"},"image":{"@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#primaryimage"},"thumbnailUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208.jpeg","datePublished":"2020-08-17T15:14:39+00:00","dateModified":"2024-11-01T17:33:32+00:00","breadcrumb":{"@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#primaryimage","url":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208.jpeg","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208.jpeg","width":1880,"height":1255},{"@type":"BreadcrumbList","@id":"https:\/\/eczemahelp.ca\/esc-advocates-for-patients-during-drug-pricing-discussions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eczemahelp.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"La SCE se porte \u00e0 la d\u00e9fense des patients pendant les discussions sur l’\u00e9tablissement des prix des m\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/eczemahelp.ca\/#website","url":"https:\/\/eczemahelp.ca\/","name":"Eczema Society of Canada","description":"Educational Resources","publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eczemahelp.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/eczemahelp.ca\/#organization","name":"Eczema Society of Canada","url":"https:\/\/eczemahelp.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/","url":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","width":362,"height":360,"caption":"Eczema Society of Canada"},"image":{"@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EczemaSocietyofCanada","https:\/\/x.com\/EczemaSocietyCA","https:\/\/www.youtube.com\/user\/EczemaHelp","https:\/\/www.instagram.com\/eczemasocietyofcanada\/"]},{"@type":"Person","@id":"https:\/\/eczemahelp.ca\/#\/schema\/person\/4d95056924d0f5c8b391739699691790","name":"ESCAdmin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/d59cdb18d6c9c6fecc51727424cc12fc.jpg?ver=1776804733","url":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/d59cdb18d6c9c6fecc51727424cc12fc.jpg?ver=1776804733","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/d59cdb18d6c9c6fecc51727424cc12fc.jpg?ver=1776804733","caption":"ESCAdmin"},"url":"https:\/\/eczemahelp.ca\/fr\/author\/escadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/3778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/comments?post=3778"}],"version-history":[{"count":0,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/3778\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/media\/2400"}],"wp:attachment":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/media?parent=3778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/categories?post=3778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/tags?post=3778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"La](\"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2020\/05\/pexels-photo-1181208-300x200.jpeg\" "\\"La")
La SCE a appris r\u00e9cemment que les changements propos\u00e9s concernant la mani\u00e8re dont les prix des m\u00e9dicaments sont fix\u00e9s au Canada (le R\u00e8glement sur les m\u00e9dicaments brevet\u00e9s) pourraient avoir une incidence n\u00e9gative sur les Canadiens atteints de dermatite atopique, couramment appel\u00e9e \u00ab ecz\u00e9ma \u00bb.<\/p>\n